By Marc Catlin A $50 billion investment to fund rural health care was in jeopardy in mid-October, when members of the U.S.

Pharmaceutical companies have agreed to slash the Medicare prices for 15 prescription drugs after months of negotiations, reductions that are expected to produce billions in savings for taxpayers and ...